Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor
- 22 June 2006
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 80 (2), 151-155
- https://doi.org/10.1007/s11060-006-9180-7
Abstract
The SOX group E transcription factors play an integral role in the specification and differentiation of astrocytes and oligodendrocytes. We have examined the pattern of expression for SOX9 and SOX10 in primary brain tumors by immunohistochemistry. Pediatric and adult high grade tumors display strong nuclear staining for both SOX9 and SOX10 (astrocytic, oligodendroglial and primitive neuroectodermal tumors). In comparison pediatric pilocytic astrocytoma express much less SOX9 and SOX10. Reactive astrogliosis is characterized by an increase of SOX9 only.This publication has 17 references indexed in Scilit:
- Oligodendroglial-specific Transcriptional Factor SOX10 is Ubiquitously Expressed in Human GliomasJournal of Neuro-Oncology, 2005
- Temporally Regulated Neural Crest Transcription Factors Distinguish Neuroectodermal Tumors of Varying Malignancy and DifferentiationNeoplasia, 2005
- Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cordDevelopmental Biology, 2005
- Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in miceOncogene, 2005
- Cancerous stem cells can arise from pediatric brain tumorsProceedings of the National Academy of Sciences of the United States of America, 2003
- The Sox9 transcription factor determines glial fate choice in the developing spinal cordGenes & Development, 2003
- Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10Genes & Development, 2002
- Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signalGlia, 2001
- From head to toes: the multiple facets of Sox proteinsNucleic Acids Research, 1999
- Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumorsAnnals of Neurology, 1996